Total Payments
$2,056
2024 Payments
$376.27
Companies
25
Transactions
135
Medicare Patients
1,224
Medicare Billing
$113,137
Payment Breakdown by Category
Food & Beverage$2,056 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,056 | 135 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $465.35 | 36 | $0 (2024) |
| ABBVIE INC. | $267.46 | 18 | $0 (2024) |
| Amgen Inc. | $197.58 | 14 | $0 (2023) |
| GlaxoSmithKline, LLC. | $188.09 | 6 | $0 (2023) |
| Merck Sharp & Dohme LLC | $164.83 | 11 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $162.06 | 11 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $76.48 | 4 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $72.28 | 5 | $0 (2022) |
| PFIZER INC. | $59.53 | 4 | $0 (2024) |
| Seqirus USA Inc | $49.00 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $376.27 | 23 | Novo Nordisk Inc ($107.92) |
| 2023 | $472.52 | 32 | Novo Nordisk Inc ($152.87) |
| 2022 | $806.66 | 52 | Novo Nordisk Inc ($188.82) |
| 2021 | $382.27 | 27 | Merck Sharp & Dohme Corporation ($87.70) |
| 2018 | $18.41 | 1 | Genentech USA, Inc. ($18.41) |
All Payment Transactions
135 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Neuroscience | ||||||
| 10/24/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: PAIN | ||||||
| 10/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Obesity | ||||||
| 10/01/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: Neuroscience | ||||||
| 09/30/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.25 | General |
| 09/23/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: VACCINE | ||||||
| 09/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Diabetes | ||||||
| 08/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: NEUROSCIENCE | ||||||
| 08/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: NEUROSCIENCE | ||||||
| 08/19/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: VACCINE | ||||||
| 06/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: NEUROSCIENCE | ||||||
| 06/03/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.87 | General |
| 05/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Diabetes | ||||||
| 05/13/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Neuroscience | ||||||
| 04/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: NEUROSCIENCE | ||||||
| 04/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: Cardio-renal | ||||||
| 04/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: NEUROSCIENCE | ||||||
| 03/18/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: VACCINE | ||||||
| 03/04/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: Diabetes | ||||||
| 02/26/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Obesity | ||||||
| 02/13/2024 | Bausch Health US, LLC | APLENZIN (Drug), WELLBUTRIN | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Neurology | ||||||
| 02/01/2024 | Seqirus USA Inc | Fluad (Biological), Flucelvax | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Vaccines | ||||||
| 01/12/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $30.78 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 539 | 689 | $181,105 | $54,856 |
| 2022 | 12 | 429 | 541 | $129,944 | $38,052 |
| 2021 | 11 | 256 | 335 | $83,464 | $20,229 |
Total Patients
1,224
Total Services
1,565
Medicare Billing
$113,137
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 69 | 69 | $29,049 | $9,812 | 33.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 60 | 96 | $30,816 | $9,262 | 30.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 79 | 105 | $22,890 | $7,765 | 33.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 18 | 18 | $8,370 | $5,082 | 60.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 40 | 74 | $18,796 | $4,965 | 26.4% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 43 | 79 | $23,226 | $4,696 | 20.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 15 | 17 | $14,178 | $4,154 | 29.3% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 23 | 33 | $14,883 | $2,894 | 19.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 30 | 30 | $5,100 | $2,158 | 42.3% |
| 99347 | Residence visit for established patient with straightforward medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 26 | 29 | $5,597 | $918.72 | 16.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 30 | 30 | $900.00 | $882.00 | 98.0% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 18 | 19 | $3,040 | $770.45 | 25.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 34 | 34 | $2,244 | $707.88 | 31.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 18 | 18 | $540.00 | $529.20 | 98.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 21 | 22 | $1,364 | $205.76 | 15.1% |
| 81002 | Urinalysis, manual test | Office | 2023 | 15 | 16 | $112.00 | $54.56 | 48.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 96 | 118 | $25,724 | $8,333 | 32.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 49 | 49 | $20,629 | $7,155 | 34.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 49 | 74 | $23,754 | $6,503 | 27.4% |
| 99335 | Established patient custodial care facility, group care, or assisted living visit, typically 25 minutes | Office | 2022 | 36 | 63 | $20,916 | $5,109 | 24.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 47 | 78 | $19,812 | $4,793 | 24.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 25 | 25 | $4,250 | $1,710 | 40.2% |
| 99334 | Established patient custodial care facility, group care, or assisted living visit, typically 15 minutes | Office | 2022 | 18 | 24 | $5,064 | $1,226 | 24.2% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 25 | 25 | $4,000 | $1,022 | 25.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 27 | 27 | $810.00 | $794.40 | 98.1% |
About Dr. Alyssa Huncken, MD
Dr. Alyssa Huncken, MD is a Family Medicine healthcare provider based in Montville, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2017. The National Provider Identifier (NPI) number assigned to this provider is 1861924565.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alyssa Huncken, MD has received a total of $2,056 in payments from pharmaceutical and medical device companies, with $376.27 received in 2024. These payments were reported across 135 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($2,056).
As a Medicare-enrolled provider, Huncken has provided services to 1,224 Medicare beneficiaries, totaling 1,565 services with total Medicare billing of $113,137. Data is available for 3 years (2021–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Montville, NJ
- Active Since 03/31/2017
- Last Updated 02/28/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1861924565
Products in Payments
- Otezla (Drug) $182.58
- JARDIANCE (Drug) $177.91
- SHINGRIX (Biological) $173.17
- UBRELVY (Drug) $117.23
- Wegovy (Drug) $106.78
- QULIPTA (Drug) $84.71
- SPRAVATO (Drug) $76.48
- JANUVIA (Drug) $73.28
- Livalo (Drug) $72.28
- VRAYLAR (Drug) $65.52
- Rybelsus (Drug) $59.63
- NURTEC ODT (Drug) $57.39
- GARDASIL (Biological) $48.44
- Ozempic (Drug) $47.33
- ENTRESTO (Drug) $44.10
- BELSOMRA (Drug) $43.11
- Prolastin-C Liquid (Biological) $41.67
- FLUCELVAX QUADRIVALENT (Biological) $32.00
- Cologuard Collection Kit (Device) $30.78
- TOSYMRA (Drug) $28.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Montville
Dr. Arnold Pallay, Md, MD
Family Medicine — Payments: $10,226
Family Medicine $10,226
Dr. Frank Iannetta, M.d, M.D
Family Medicine — Payments: $6,224
Family Medicine $6,224
Thomas Stack, D.o, D.O
Family Medicine — Payments: $3,310
Family Medicine $3,310
Dr. Pareen Lapsiwala, D.o, D.O
Family Medicine — Payments: $970.16
Family Medicine $970.16
Zunera Yaqub, M.d, M.D
Family Medicine — Payments: $831.03
Family Medicine $831.03
Dr. Sandra Hoenig, M.d,, M.D,
Family Medicine — Payments: $720.56
Family Medicine $720.56